110 related articles for article (PubMed ID: 15993264)
21. [Two cases of tardive Tourette syndrome].
Yamauchi K; Ohmori T
Seishin Shinkeigaku Zasshi; 2006; 108(5):459-65. PubMed ID: 16869393
[TBL] [Abstract][Full Text] [Related]
22. Risperidone in idiopathic and symptomatic dystonia: preliminary experience.
Grassi E; Latorraca S; Piacentini S; Marini P; Sorbi S
Neurol Sci; 2000 Apr; 21(2):121-3. PubMed ID: 10938193
[TBL] [Abstract][Full Text] [Related]
23. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
[TBL] [Abstract][Full Text] [Related]
24. A retrospective chart review of the antiemetic effectiveness of risperidone in refractory opioid-induced nausea and vomiting in advanced cancer patients.
Okamoto Y; Tsuneto S; Matsuda Y; Inoue T; Tanimukai H; Tazumi K; Ono Y; Kurokawa N; Uejima E
J Pain Symptom Manage; 2007 Aug; 34(2):217-22. PubMed ID: 17544249
[TBL] [Abstract][Full Text] [Related]
25. Long-term administration of the low-dose risperidone in schizotaxia subjects.
Rybakowski JK; Drozdz W; Borkowska A
Hum Psychopharmacol; 2007 Aug; 22(6):407-12. PubMed ID: 17597479
[TBL] [Abstract][Full Text] [Related]
26. Risperidone for the treatment of stuttering.
Maguire GA; Riley GD; Franklin DL; Gottschalk LA
J Clin Psychopharmacol; 2000 Aug; 20(4):479-82. PubMed ID: 10917410
[TBL] [Abstract][Full Text] [Related]
27. Acute dyskinesia on starting methylphenidate after risperidone withdrawal.
Hollis CP; Thompson A
Pediatr Neurol; 2007 Oct; 37(4):287-8. PubMed ID: 17903675
[TBL] [Abstract][Full Text] [Related]
28. Predictors for starting depot administration of risperidone in chronic users of antipsychotics.
Vehof J; Postma MJ; Bruggeman R; De Jong-Van Den Berg LT; Van Den Berg PB; Stolk RP; Burger H
J Clin Psychopharmacol; 2008 Dec; 28(6):625-30. PubMed ID: 19011430
[TBL] [Abstract][Full Text] [Related]
29. Delusional parasitosis presenting as folie à trois: successful treatment with risperidone.
Friedmann AC; Ekeowa-Anderson A; Taylor R; Bewley A
Br J Dermatol; 2006 Oct; 155(4):841-2. PubMed ID: 16965440
[No Abstract] [Full Text] [Related]
30. Risperidone attenuates brain damage after focal cerebral ischemia in vivo.
Yulug B; Yildiz A; Güzel O; Kilic E; Schäbitz WR; Kilic E
Brain Res Bull; 2006 May; 69(6):656-9. PubMed ID: 16716834
[TBL] [Abstract][Full Text] [Related]
31. Body mass index changes and chronic neuroleptic drug treatment for Tourette syndrome.
Degrauw RS; Li JZ; Gilbert DL
Pediatr Neurol; 2009 Sep; 41(3):183-6. PubMed ID: 19664533
[TBL] [Abstract][Full Text] [Related]
32. Pavor nocturnus.
SPERLING M
J Am Psychoanal Assoc; 1958 Jan; 6(1):79-94. PubMed ID: 13502232
[No Abstract] [Full Text] [Related]
33. Choice of and decreasing of the dosage of risperidone in the treatment of schizophrenia. Global versus individual criteria.
Gómez-Perretta C
Actas Esp Psiquiatr; 2007; 35(1):77-8. PubMed ID: 17323229
[No Abstract] [Full Text] [Related]
34. Pavor nocturnus.
STERN MM
Int J Psychoanal; 1951; 32(4):302-9. PubMed ID: 14880307
[No Abstract] [Full Text] [Related]
35. [Pavor nocturnus, nightmare, and somnabulism].
DE MORAGAS J
Rev Esp Pediatr; 1952; 8(1):47-59. PubMed ID: 14921016
[No Abstract] [Full Text] [Related]
36. Tardive dyskinesia in a pregnant woman with low dose, short-duration risperidone: possible role of estrogen-induced dopaminergic hypersensitivity.
Chatterjee B; Sharan P
J Neuropsychiatry Clin Neurosci; 2014; 26(1):E44-6. PubMed ID: 24515710
[No Abstract] [Full Text] [Related]
37. A 12-month, open-label, comparative study of quetiapine and risperidone in the acute and long-term treatment of schizophrenia.
Perez V; Cañas F; Tafalla M;
Int Clin Psychopharmacol; 2008 May; 23(3):138-49. PubMed ID: 18408528
[TBL] [Abstract][Full Text] [Related]
38. [Etiology and therapy of pavor nocturnus].
SCHWIDDER W
Dtsch Med J; 1951 Sep; 2(17-18):422-4. PubMed ID: 14887499
[No Abstract] [Full Text] [Related]
39. Risperidone treatment in a case of Tourette syndrome with factor V Leiden heterozygous mutation.
Sarı BA; Taşkıntuna N; Yalçın Ö
J Child Adolesc Psychopharmacol; 2014 May; 24(4):235-6. PubMed ID: 24815337
[No Abstract] [Full Text] [Related]
40. Epileptic pavor nocturnus.
Huppertz HJ; Schulze-Bonhage A
Epilepsia; 2001 May; 42(5):704. PubMed ID: 11380582
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
